2022 annual financial data
Fennec Pharmaceuticals 2022 Operating margin
Fennec Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -1,481.3%.
Operating income was -22,738,000 USD and net income was -23,714,000 USD.
Operating cash flow was -18,058,000 USD.
Get free Fennec Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,535,000 USD
- Operating income
- -22,738,000 USD
- Net income
- -23,714,000 USD
- Operating cash flow
- -18,058,000 USD